✦ LIBER ✦

Recurrent hepatitis C virus disease after liver transplantation and concurrent biliary tract complications: poor outcome

✍ Scribed by Lior H. Katz; Eitan Mor; Marius Brown; Nathan Bar-Nathan; Ezra Shaharabani; Jaqueline Sulkes; Orit Pappo; Ran Tur-Kaspa; Ziv Ben-Ari

Book ID: 110889687
Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 117 KB
Volume: 20
Category: Article
ISSN: 0902-0063
DOI: 10.1111/j.1399-0012.2006.00507.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Biliary tract complications after liver

Biliary tract complications after liver transplantation: type, management, and outcome

✍ J Torras; L Lladó; J Figueras; E Ramos; C Lama; J Fabregat; A Rafecas; E Escalan 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Do viral genotypes and HLA matching infl

Do viral genotypes and HLA matching influence the outcome of recurrent hepatitis C virus infection after liver transplantation?

✍ González-Peralta, Regino P. ;Lau, Johnson Y 📂 Article 📅 1998 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 75 KB 👁 1 views

H epatitis C virus (HCV) infection is a global health problem. The importance of HCV infection lies in its propensity to cause insidious and progressive liver damage, including chronic hepatitis, cirrhosis, and hepatocellular carcinoma. The clinical and financial impact of HCV infection on this nati

Digital image analysis of liver collagen

Digital image analysis of liver collagen predicts clinical outcome of recurrent hepatitis C Virus 1 year after liver transplantation

✍ Pinelopi Manousou; Amar P. Dhillon; Graziela Isgro; Vincenza Calvaruso; T.V. Luo 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 535 KB

Clinical outcomes of recurrent hepatitis C virus after liver transplantation are difficult to predict. We evaluated collagen proportionate area (CPA), a quantitative histological index, at 1 year with respect to the first episode of clinical decompensation. Patients with biopsies at 1 year after liv

Impact of donor graft steatosis on overa

Impact of donor graft steatosis on overall outcome and viral recurrence after liver transplantation for hepatitis C virus cirrhosis

✍ Javier Briceño; Ruben Ciria; María Pleguezuelo; Manuel de la Mata; Jordi Muntané 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 447 KB 👁 1 views

The aim of this study was to determine the influence of donor graft steatosis on overall outcome, viral recurrence, and fibrosis progression in orthotopic liver transplantation (OLT) for hepatitis C virus (HCV) cirrhosis. One hundred twenty patients who underwent OLT for HCV cirrhosis between 1995 a

Outcome of recurrent hepatitis C virus a

Outcome of recurrent hepatitis C virus after liver transplantation in a randomized trial of tacrolimus monotherapy versus triple therapy

✍ Pinelopi Manousou; Dimitrios Samonakis; Evangelos Cholongitas; David Patch; Jame 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 181 KB 👁 2 views

Less potent immunosuppression is considered to reduce the severity of hepatitis C virus (HCV) recurrence after liver transplantation. An optimal regimen is unknown. We evaluated tacrolimus monotherapy versus triple therapy in a randomized trial of 103 first transplants for HCV cirrhosis. One hundred

Reply: Outcome of recurrent hepatitis C

Reply: Outcome of recurrent hepatitis C virus after liver transplantation in a randomized trial of tacrolimus monotherapy versus triple therapy

✍ Dinesh Jothimani; Timothy J. S. Cross 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 36 KB 👁 1 views

We read with interest the article by Manousou and colleagues, 1 investigating the impact of tacrolimus monotherapy (MT) versus triple therapy (TT) on recurrent hepatitis C infection after liver transplantation. This study examined hepatic fibrosis progression in patients randomized to tacrolimus MT